Invention Grant
- Patent Title: Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases
-
Application No.: US17411789Application Date: 2021-08-25
-
Publication No.: US11359199B2Publication Date: 2022-06-14
- Inventor: Peter Jungsoo Park , Jin Kuk Kim , Timothy Yu , Yu-Han Huang
- Applicant: PRESIDENT AND FELLOWS OF HARVARD COLLEGE , THE CHILDREN'S MEDICAL CENTER CORPORATION
- Applicant Address: US MA Cambridge; US MA Cambridge
- Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE,THE CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE,THE CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee Address: US MA Cambridge; US MA Cambridge
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Mark J. Fitzgerald
- Main IPC: C12N15/113
- IPC: C12N15/113
Abstract:
Described herein are methods and compositions related to the modulation of progranulin expression or activity in the brain for the treatment of neurodegenerative diseases.
Public/Granted literature
- US20210380982A1 ANTISENSE OLIGONUCLEOTIDE-BASED PROGRANULIN AUGMENTATION THERAPY IN NEURODEGENERATIVE DISEASES Public/Granted day:2021-12-09
Information query
IPC分类:
